Predictive modeling of anti-cancer drug sensitivity from genetic characterizations

Abstract

Accurately predicting sensitivity of tumor cells to anti-cancer drugs based on genetic characterizations is a significant challenge for personalized cancer therapy. This chapter provides a computational procedure to design predictive models from individual genomic characterizations and combine them to arrive at an integrated predictive model. Integrated modeling employs the complementary information from heterogeneous genetic characterizations to improve the prediction error as well as lowering the error confidence interval.